FELIX OYUGI-SUMMERS: Open Payments
NPI 1174288849 · DESTIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 35 payments from 16 companies in 2025. Trend: 2023 $796 · 2024 $1,512 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 6 | $135 |
| Xeris Pharmaceuticals, Inc. | 4 | $105 |
| Medtronic, Inc. | 3 | $68 |
| IBSA Pharma Inc. | 3 | $67 |
| Tandem Diabetes Care, Inc. | 3 | $64 |
| Sequel Med Tech, LLC | 3 | $52 |
| Insulet Corporation | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Amneal Pharmaceuticals LLC | 2 | $35 |
| Corcept Therapeutics | 1 | $32 |
Products named: iLet Bionic Pancreas, MINIMED 780G, Tirosint, t:slim X2 Insulin Pump with Control-IQ, RECORLEV, TWIIST, GVOKE HYPOPEN, Omnipod.
Industry payments across FL — which companies pay providers there.
